Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49. Viewpoint Jan 2021 The Nazi Analogy Muddles Our Thinking About Physician Aid-in-Dying in the US Holland M. Kaplan, MD Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations. AMA J Ethics. 2021;23(1):E78-81. doi: 10.1001/amajethics.2021.78 Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029. Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. Case and Commentary May 2006 Stigmatized Patients' Right to Equal Treatment Kelly D. Brownell, PhD and Rebecca M. Puhl, PhD Virtual Mentor. 2006;8(5):298-302. doi: 10.1001/virtualmentor.2006.8.5.ccas1-0605. Policy Forum Jan 2006 What Good Is Hypertension Screening If You Don't Do Anything About It? Christian J. Krautkramer Virtual Mentor. 2006;8(1):42-47. doi: 10.1001/virtualmentor.2006.8.1.pfor1-0601. Case and Commentary Feb 2007 Ethics of Cutting-Edge Device Research Harvey L. Gordon, MD Virtual Mentor. 2007;9(2):86-90. doi: 10.1001/virtualmentor.2007.9.2.ccas1-0702. Case and Commentary Feb 2007 Turning Off an Implanted Life-Saving Device, Commentary 1 Lofty L. Basta, MD Virtual Mentor. 2007;9(2):91-96. doi: 10.1001/virtualmentor.2007.9.2.ccas2-0702. Case and Commentary Feb 2007 Turning Off an Implanted Life-Saving Device, Commentary 2 Katrina A. Bramstedt, PhD Virtual Mentor. 2007;9(2):96-98. doi: 10.1001/virtualmentor.2007.9.2.ccas2-0702. Case and Commentary Jun 2005 When Depression Affects Treatment Decisions Jason A. Hughes, MD and Mark A. Graber, MD Virtual Mentor. 2005;7(6):412-416. doi: 10.1001/virtualmentor.2005.7.6.ccas3-0506. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49.
Viewpoint Jan 2021 The Nazi Analogy Muddles Our Thinking About Physician Aid-in-Dying in the US Holland M. Kaplan, MD Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations. AMA J Ethics. 2021;23(1):E78-81. doi: 10.1001/amajethics.2021.78
Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029.
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
Case and Commentary May 2006 Stigmatized Patients' Right to Equal Treatment Kelly D. Brownell, PhD and Rebecca M. Puhl, PhD Virtual Mentor. 2006;8(5):298-302. doi: 10.1001/virtualmentor.2006.8.5.ccas1-0605.
Policy Forum Jan 2006 What Good Is Hypertension Screening If You Don't Do Anything About It? Christian J. Krautkramer Virtual Mentor. 2006;8(1):42-47. doi: 10.1001/virtualmentor.2006.8.1.pfor1-0601.
Case and Commentary Feb 2007 Ethics of Cutting-Edge Device Research Harvey L. Gordon, MD Virtual Mentor. 2007;9(2):86-90. doi: 10.1001/virtualmentor.2007.9.2.ccas1-0702.
Case and Commentary Feb 2007 Turning Off an Implanted Life-Saving Device, Commentary 1 Lofty L. Basta, MD Virtual Mentor. 2007;9(2):91-96. doi: 10.1001/virtualmentor.2007.9.2.ccas2-0702.
Case and Commentary Feb 2007 Turning Off an Implanted Life-Saving Device, Commentary 2 Katrina A. Bramstedt, PhD Virtual Mentor. 2007;9(2):96-98. doi: 10.1001/virtualmentor.2007.9.2.ccas2-0702.
Case and Commentary Jun 2005 When Depression Affects Treatment Decisions Jason A. Hughes, MD and Mark A. Graber, MD Virtual Mentor. 2005;7(6):412-416. doi: 10.1001/virtualmentor.2005.7.6.ccas3-0506.